EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Paths to hippocampal damage in neuromyelitis optica spectrum disorders

Mona Zakani, Magdalini Nigritinou, Markus Ponleitner, Yoshiki Takai, Daniel Hofmann, Sophie Hillebrand, Romana Höftberger, Jan Bauer, Balint Lasztoczi, Tatsuro Misu, Gregor Kasprian, Paulus Rommer und 1 weitere

Neuropathology and Applied Neurobiology · 2023-04 · 49 (2)

DOI: 10.1111/nan.12893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 06.03.2023. Verfasst von Mona Zakani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Neuromyelitis Optica. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Many patients with neuromyelitis optica spectrum disorders (NMOSD) suffer from cognitive impairment affecting memory, processing speed and attention and suffer from depressive symptoms. Because some of these manifestations could trace back to the hippocampus, several magnetic resonance imaging (MRI) studies have been performed in the past, with a number of groups describing volume loss of the hippocampus in NMOSD patients, whereas others did not observe such changes. Here, we addressed these discrepancies.

Methods

We performed pathological and MRI studies on the hippocampi of NMOSD patients, combined with detailed immunohistochemical analysis of hippocampi from experimental models of NMOSD.

Results

We identified different pathological scenarios for hippocampal damage in NMOSD and its experimental models. In the first case, the hippocampus was compromised by the initiation of astrocyte injury in this brain region and subsequent local effects of microglial activation and neuronal damage. In the second case, loss of hippocampal volume was seen by MRI in patients with large tissue‐destructive lesions in the optic nerves or the spinal cord, and the pathological work‐up of tissue derived from a patient with such lesions revealed subsequent retrograde neuronal degeneration affecting different axonal tracts and neuronal networks. It remains to be seen whether remote lesions and associated retrograde neuronal degeneration on their own are sufficient to cause extensive volume loss of the hippocampus, or whether they act in concert with small astrocyte‐destructive, microglia‐activating lesions in the hippocampus that escape detection by MRI, either due to their small size or due to the chosen time window for examination.

Conclusions

Different pathological scenarios can culminate in hippocampal volume loss in NMOSD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuromyelitis OpticaHumansSpinal CordBrainMagnetic Resonance ImagingHippocampusAutoantibodiesAquaporin 4

Stichwörter der Autor:innen

aquaporin 4hippocampusmicroglial activationneuromyelitis opticaretrograde degeneration

Substanzen

AutoantibodiesAquaporin 4

Autor:innen und Institutionen

  • Division of Neuroimmunology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
  • Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Neurology, Division of Neuropathology and Neurochemistry, Medical University of Vienna, Vienna, Austria.
  • Division of Cognitive Neurobiology, Center for Brain Research, Medical University of Vienna, Vienna, Austria.
  • Division of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Förderung

  • Austrian Science Fund FWF
  • Austrian Science Fund

Zitieren

APA

Zakani, M., Nigritinou, M., Ponleitner, M., Takai, Y., Hofmann, D., Hillebrand, S., Höftberger, R., Bauer, J., Lasztoczi, B., Misu, T., Kasprian, G., Rommer, P., & Bradl, M. (2023). Paths to hippocampal damage in neuromyelitis optica spectrum disorders. Neuropathology and Applied Neurobiology, 49(2). https://doi.org/10.1111/nan.12893

Vancouver

Zakani M, Nigritinou M, Ponleitner M, Takai Y, Hofmann D, Hillebrand S, et al. Paths to hippocampal damage in neuromyelitis optica spectrum disorders. Neuropathology and Applied Neurobiology. 2023;49(2). doi:10.1111/nan.12893

BibTeX
@article{Zakani2023,
  author = {Zakani, Mona and Nigritinou, Magdalini and Ponleitner, Markus and Takai, Yoshiki and Hofmann, Daniel and Hillebrand, Sophie and Höftberger, Romana and Bauer, Jan and Lasztoczi, Balint and Misu, Tatsuro and Kasprian, Gregor and Rommer, Paulus and Bradl, Monika},
  title = {Paths to hippocampal damage in neuromyelitis optica spectrum disorders},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2023},
  volume = {49},
  number = {2},
  doi = {10.1111/nan.12893}
}
Kostenlos starten →